Skip to main content
Corexel

Health Analytics · 2024

NeuroLink Diagnostics

AI-assisted health analytics with secure clinical dashboard

Automated analytics workflows with AI-assisted analysis, medical visualization, and secure healthcare reporting.

  • AI-assisted analysis
  • Medical visualization
  • Secure dashboard
NeuroLink Diagnostics systems architecture

Context

Problem framing

NeuroLink Diagnostics instruments produce high-rate waveform data that clinicians review under time pressure. Dropped samples or ambiguous timestamps erode trust immediately.

Challenge

Constraints

Ingestion at scale, synchronized timestamps across devices, and dashboards that remain responsive during batch imports from clinic uploads.

Architecture

System design

Time-series store with ingestion validators, waveform rendering optimized for clinical review paths, and batch import jobs with progress and error surfacing to lab staff.

Delivery

How we shipped

Pilot clinics validated upload and review flows; ingestion drop rate near zero after validator tuning. NeuroLink lab ops inherited import runbooks and escalation paths.

Related work

MedAxis Intelligence — Secure diagnostic workflow platform with medical data visualization

Healthcare Technology · 2024

MedAxis Intelligence

Secure diagnostic workflow platform with medical data visualization

Built HIPAA-aligned reporting dashboards, diagnostic workflows, and AI-assisted analytics with improved clinical usability.

  • Diagnostic workflows
  • Secure reporting
  • AI-assisted analytics
BioCircuit Systems — Medical telemetry architecture with embedded diagnostics hardware

Biomedical Engineering · 2023

BioCircuit Systems

Medical telemetry architecture with embedded diagnostics hardware

Integrated sensor processing, device communication, and real-time monitoring for biomedical telemetry products.

  • Medical telemetry
  • Embedded diagnostics
  • Real-time monitoring
← Back to portfolio

Engage

Discuss your system with engineering.

Share architecture constraints and success criteria. We respond with scope, risks, and an honest path forward.